Linee guida SISET in Ostetricia e Ginecologia - Terapia compressiva

20
1995;346:1593-6.
150. Aznar J, Vaya A, Estelles A, Mira Y, Segui R, Villa P, et al. Risk
of venous thrombosis in carriers of the prothrombin G20210A
variant and factor V Leiden and their interaction with oral
contraceptives. Haematologica 2000;85:1271-6.
151. Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM.
High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene
mutation and in users of oral contraceptives.
N Engl J Med 1998;338:1840-1.
152. Pabinger I, Schneider B. Thrombotic risk of women with
hereditary antithrombin III-protein C-and protein S-deficiency
taking oral contraceptive medication. The GTH Study
Group on Natural Inhibitors. Thromb Haemost 1994;71:548-
52.
153. Cosmi B, Legnani C, Bernardi F, Coccheri S, Palareti G. Value
of family history in identifying women at risk of venous
thromboembolism during oral contraception: observational
study. Br Med J 2001;322:1024-5.
154. Kluft C, Lansink M. Effects of oral contraceptives on
haemostasis variables. Thromb Haemost 1997;78:315-26.
155. Rosing J, Middeldorp S, Curvers J, Christella M, Thomassen LG,
Nicolaes GA, et al. Low-dose oral contraceptives and acquired
resistance to activated protein C: a randomised cross-over
study. Lancet 1999;354:2036-40.
156. Middeldorp S, Meijers JC, van den Ende AE, van Enk A, Bouma
BN, Tans G, et al. Effects on coagulation of levonorgestreland
desogestrel-containing low dose oral contraceptives: a
cross-over study. Thromb Haemost 2000;84:4-8.
157. Tans G, Curvers J, Middeldorp S, Thomassen MC, Meijers JC,
Prins MH, et al. A randomized cross-over study on the effects
of levonorgestrel- and desogestrel-containing oral contraceptives
on the anticoagulant pathways. Thromb Haemost
2000;84:15-21.
158. Rosendaal FR, Helmerhorst FM, Vandenbroucke JP. Oral contraceptives,
hormone replacement therapy and thrombosis.
Thromb Haemost 2001;86:112-23
159. Meade TW. Hormone replacement therapy and haemostatic
function. Thromb Haemost 1997;79:765-9.
160. Effects of estrogen or estrogen/progestin regimens on heart
disease risk factors in postmenopausal women. The Postmenopausal
Estrogen/Progestin Interventions (PEPI) Trial. The
haematologica vol. 87(supplement to n. 12):2002
E. Grandone et al.
Writing Group for the PEPI Trial. JAMA 1995;273:199-208.
161. Meade TW, Dyer S, Howarth DJ, Imeson JD, Stirling Y.
Antithrombin III and procoagulant activity: sex differences
and effects of the menopause. Br J Haematol 1990;74:77-81.
162. Meade TW. Hormone replacement therapy and haemostatic
function. Thromb Haemost 1997;79:765-9.
163. Kroon UB, Silfverstolpe G, Tengborn L. The effect of transdermal
estradiol and oral conjugated estrogens on haemostasis
variables. Thromb Haemost 1994;71:420-2.
164. Daly E, Vessey MP, Hawkins MM, Carson JL, Gough P, Marsh
S. Risk of venous thromboembolism in users of hormone
replacement therapy. Lancet 1996;348:977-80.
165. Jick H, Derby LE, Myers MW, Vasilakis C, Newton KM. Risk of
hospital admission for idiopatic venous thromboembolism
among users of postmenopausal oestrogen. Lancet 1996;
348:981-3.
166. Pérez Gutthann S, Garcia Rodriguez LA, Castellsague J, Oliart
AD. Hormone replacement therapy and risk of venous thromboembolism:population
based case-control study. Br Med J
1997;314:796-800.
167. Grodstein F, Stampfer MJ, Goldhaber SZ, Manson JE, Colditz
GA, Speizer FE, et al. Prospective study of exogenous hormones
and risk of pulmonary embolism in women. Lancet
1996;348:983-7.
168. McKenna MJ. Risk of venous thrombosis with hormone
raplacement therapy. Lancet 1996;348:1668.
169. Hoibraaten E, Qvigstad E, Arnesen H, Larsen S, Wickstrom E,
Sandset PM. Increased risk of recurrent venous thromboembolism
during hormone replacement therapy-results of the
randomized, double-blind, placebo-controlled estrogen in
venous thromboembolism trial (EVTET). Thromb Haemost
2000;84:961-7.
170. Grady D, Wenger NK, Herrington D, Khan S, Furberg C, Hunninghake
D, et al. Postmenopausal hormone therapy increases
risk for venous thromboembolic disease. The Heart and
Estrogen/progestin Replacement Study. Ann Intern Med
2000;132:689-96.
171. Rosendaal FR, Vessey M, Rumley A, Daly E, Woodward M,
Helmerhorst FM, et al. Hormonal replacement therapy, prothrombotic
mutations and the risk of venous thrombosis. Br
J Haematol 2002; 116:851-4.